Related Experiment Video

Updated: May 13, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection

Published on: September 1, 2023

Effect of the PA-MSHA vaccine on septic serum-induced inflammatory response

Xiang-Feng Liu1, Li Wang, Yi Qu

  • 1Department of General Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.

Molecular Medicine Reports
|February 27, 2013
PubMed

Insights

A Pseudomonas aeruginosa outer membrane protein vaccine (PA-MSHA) modulates sepsis-induced inflammation. It reduces pro-inflammatory tumor necrosis factor-alpha and increases anti-inflammatory interleukin-10 and regulatory T cells.

Area of Science:

  • Immunology
  • Microbiology
  • Sepsis Pathophysiology

Background:

  • Sepsis is a life-threatening condition characterized by dysregulated inflammation following infection.
  • Current treatments for sepsis have limitations, highlighting the need for novel therapeutic strategies.
  • Outer membrane proteins from Pseudomonas aeruginosa (PA-MSHA) show potential immune-modulatory effects.

Purpose of the Study:

  • To investigate the immunomodulatory effects of the PA-MSHA vaccine on inflammatory responses in sepsis.
  • To determine the impact of PA-MSHA on peripheral blood mononuclear cells exposed to septic patient serum.

Main Methods:

  • Peripheral blood mononuclear cells were pretreated with the PA-MSHA vaccine.
  • Cells were subsequently stimulated with serum from patients diagnosed with sepsis.
  • Levels of key inflammatory cytokines (TNF-α, IL-10) and T cell populations (CD4+CD25+Foxp3+) were analyzed.

Main Results:

  • PA-MSHA pretreatment significantly inhibited the production of tumor necrosis factor-alpha induced by septic serum.
  • PA-MSHA treatment led to increased levels of the anti-inflammatory cytokine interleukin-10.
  • The vaccine promoted the generation of CD4+CD25+Foxp3+ regulatory T cells.

Conclusions:

  • The PA-MSHA vaccine demonstrates potent immune-modulatory properties relevant to sepsis.
  • PA-MSHA may offer a therapeutic approach by rebalancing the inflammatory response in sepsis.
  • These findings provide mechanistic insights into the potential clinical application of PA-MSHA for sepsis treatment.

More Related Videos

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis06:57

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...